Invention Application
WO2016089553A1 EARLY DETECTION OF HEPATOCELLULAR CARCINOMA IN HIGH RISK POPULATIONS USING MALDI-TOF MASS SPECTROMETRY
审中-公开
使用MALDI-TOF质谱法检测高风险人群中的肝细胞癌
- Patent Title: EARLY DETECTION OF HEPATOCELLULAR CARCINOMA IN HIGH RISK POPULATIONS USING MALDI-TOF MASS SPECTROMETRY
- Patent Title (中): 使用MALDI-TOF质谱法检测高风险人群中的肝细胞癌
-
Application No.: PCT/US2015/059865Application Date: 2015-11-10
-
Publication No.: WO2016089553A1Publication Date: 2016-06-09
- Inventor: RÖDER, Joanna , OLIVEIRA, Carlos , GRIGORIEVA, Julia , RÖDER, Heinrich , MAHALINGHAM, Devalingham
- Applicant: BIODESIX, INC.
- Applicant Address: 2970 Wildmess Place Suite 100 Boulder, CO 80301 US
- Assignee: BIODESIX, INC.
- Current Assignee: BIODESIX, INC.
- Current Assignee Address: 2970 Wildmess Place Suite 100 Boulder, CO 80301 US
- Agency: HILLMAN, Lisa, M.W.
- Priority: US62/086,805 20141203
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N24/00 ; H01J49/00
Abstract:
Hepatocellular carcinoma (HCC) is detected in a patient with liver disease. Mass spectrometry data from a blood-based sample from the patient is compared to a reference set of mass-spectrometry data from a multitude of other patients with liver disease, including patients with and without HCC, in a general purpose computer configured as a classifier. The classifier generates a class label, such as HCC or No HCC, for the test sample, A laboratory system for early detection of HCC in patients with liver disease is also disclosed. Alternative testing strategies using AFP measurement and a reference set for classification in the form of class-labeled mass spectral data from blood-based samples of lung cancer patients are also described, including multi-stage testing.
Information query
IPC分类: